Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C21H26N2O4.ClH |
Molecular Weight | 406.903 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=C(OC)C=C(C=C1)[C@H](O)CN2CCN(CC2)C3=CC=CC=CC3=O
InChI
InChIKey=UIOUCVPFPQUSAS-FSRHSHDFSA-N
InChI=1S/C21H26N2O4.ClH/c1-26-20-9-8-16(14-21(20)27-2)19(25)15-22-10-12-23(13-11-22)17-6-4-3-5-7-18(17)24;/h3-9,14,19,25H,10-13,15H2,1-2H3;1H/t19-;/m1./s1
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C21H26N2O4 |
Molecular Weight | 370.4421 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Ciladopa, is a troponylpiperazine derivative and dopamine agonist that has been shown to influence dopaminergic mechanisms in animals. Preclinical pharmacological studies have suggested that it has antiparkinsonian activity similar to that of bromocriptine but without many of the troublesome side effects. Unfortunately in some clinical trials no significant differences was found among the treatment groups and placebo.
CNS Activity
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: P14416 Gene ID: 1813.0 Gene Symbol: DRD2 Target Organism: Homo sapiens (Human) Sources: https://www.ncbi.nlm.nih.gov/pubmed/3774130 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3606037
15 mg twice daily for 8 weeks
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:32:03 GMT 2023
by
admin
on
Fri Dec 15 15:32:03 GMT 2023
|
Record UNII |
ASR1NR721I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL2110793
Created by
admin on Fri Dec 15 15:32:03 GMT 2023 , Edited by admin on Fri Dec 15 15:32:03 GMT 2023
|
PRIMARY | |||
|
11954350
Created by
admin on Fri Dec 15 15:32:03 GMT 2023 , Edited by admin on Fri Dec 15 15:32:03 GMT 2023
|
PRIMARY | |||
|
U-40
Created by
admin on Fri Dec 15 15:32:03 GMT 2023 , Edited by admin on Fri Dec 15 15:32:03 GMT 2023
|
PRIMARY | |||
|
C171776
Created by
admin on Fri Dec 15 15:32:03 GMT 2023 , Edited by admin on Fri Dec 15 15:32:03 GMT 2023
|
PRIMARY | |||
|
ASR1NR721I
Created by
admin on Fri Dec 15 15:32:03 GMT 2023 , Edited by admin on Fri Dec 15 15:32:03 GMT 2023
|
PRIMARY | |||
|
83529-09-3
Created by
admin on Fri Dec 15 15:32:03 GMT 2023 , Edited by admin on Fri Dec 15 15:32:03 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |